Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT03870516

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03870516
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03870516. Non-randomized; no masking; primary purpose diagnostic. Start 2021-09-20 (anticipated); primary completion 2023-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery
Condition
Mitral Regurgitation
Intervention (Procedure)
Mitral valve replacement
Intervention (Device)
Speckle tracking echocardiography
Lead sponsor
Assiut University (class: other)

Record details

Record id
cardio:ct-nct03870516
Content hash
b522bdc292873c875cf7b9e87224bb6093ce40a575157363f5eab23dd469d88e